Posted in | Pharmaceuticals and Drug Discovery

Improving seized drug analysis with LC-TOF MS screening

From Waters Advanced Diagnostics Jul 25 2026

The rapid emergence of new psychoactive substances and increasingly complex drug formulations has made comprehensive screening workflows essential for forensic laboratories. High-resolution mass spectrometry offers the sensitivity, accuracy, and speed needed to efficiently identify compounds in seized drug samples.

In this webinar, experts discuss the development and implementation of an efficient LC-TOF MS screening workflow for seized drug analysis using the ACQUITY UPLC System with the RDa Detector.

The session explores how the workflow was designed to deliver comprehensive screening while addressing the key analytical and operational requirements of modern forensic drug testing laboratories.

Other Webinars from Waters Advanced Diagnostics

Leveraging RADIAN-ASAP in Standard Casework - Insights from industry experts

Leveraging RADIAN-ASAP in Standard Casework - Insights from industry experts

Uncharted territory: Innovative approaches to novel benzodiazepine analysis in toxicology

Uncharted territory: Innovative approaches to novel benzodiazepine analysis in toxicology

Salivary Cortisone in the Investigation of Adrenal Disease by LC-MS/MS

Salivary Cortisone in the Investigation of Adrenal Disease by LC-MS/MS

Broad Spectrum and High Sensitivity Toxicology Screening by Tandem Mass Spectrometry in Emergency Department

Broad Spectrum and High Sensitivity Toxicology Screening by Tandem Mass Spectrometry in Emergency Department

Advancing toxicology screening with next-generation HRMS

Advancing toxicology screening with next-generation HRMS

Rapid explosive trace screening with RADIAN™ ASAP mass spectrometry

Rapid explosive trace screening with RADIAN™ ASAP mass spectrometry

Targeted MRM analysis for fentalogues and nitazene derivatives

Targeted MRM analysis for fentalogues and nitazene derivatives

Life Science Webinars by Subject Matter

Watch the
Webinar

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.